Market revenue in 2023 | USD 503,419.9 million |
Market revenue in 2030 | USD 913,650.8 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Conventional drugs (small molecules) |
Fastest growing segment | Conventional Drugs (Small Molecules) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 54.39% in 2023. Horizon Databook has segmented the Global pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmaceutical manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Molecule Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 135,307.3 | 140,849.5 | 155,258.1 | 183,802.9 | 197,549.5 | 207,906.1 | 219,770.9 | 237,065.2 | 256,186.8 | 277,345.4 | 300,778.9 | 326,757.4 | 355,588.4 | 8.0% |
Europe | 112,389.8 | 117,212.2 | 128,349.5 | 151,395.0 | 163,836.6 | 173,768.6 | 184,945.0 | 200,326.5 | 217,379.2 | 236,302.8 | 257,324.4 | 280,703.0 | 306,734.1 | 8.5% |
Asia Pacific | 57,218.8 | 60,498.4 | 66,776.0 | 79,550.6 | 88,759.4 | 97,068.5 | 106,411.7 | 118,480.9 | 132,112.5 | 147,526.9 | 164,978.2 | 184,760.3 | 207,213.6 | 11.4% |
Latin America | 10,248.1 | 10,620.8 | 11,488.0 | 13,409.1 | 14,659.9 | 15,708.7 | 16,871.3 | 18,399.5 | 20,092.9 | 21,971.0 | 24,055.9 | 26,372.6 | 28,949.5 | 9.1% |
MEA | 6,483.6 | 6,555.8 | 6,810.9 | 7,657.6 | 8,372.4 | 8,968.0 | 9,595.4 | 10,364.5 | 11,192.6 | 12,083.2 | 13,040.0 | 14,066.3 | 15,165.2 | 7.8% |
Overall | 321,647.6 | 335,736.7 | 368,682.4 | 435,815.2 | 473,177.9 | 503,419.9 | 537,594.2 | 584,636.5 | 636,964.0 | 695,229.3 | 760,177.3 | 832,659.6 | 913,650.8 | 8.9% |
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account